TSRTC Free Bus Scheme Leaves Rs 3,785 Crore Gap

According to the figures cited in the Telangana Assembly, the government acknowledged that it owed TSRTC about Rs 1,834 crore from the 2024-25 through 2026-27 fiscal years. Once the cost of the Mahalakshmi scheme’s zero-ticket rides since December 2023 is included, transport officials say the total unpaid amount rises to more than Rs 3,785 crore. The state has budgeted Rs 10,433.89 crore for the scheme since Congress came to power, but has released only Rs 8,599.55 crore.

The gap is important because the subsidy is not a one-off payment. It is a recurring operating support mechanism for one of India’s largest state-run bus operators, and it comes on top of other obligations such as loan repayments, concessions for students and other groups, and spending for new buses and depots. TSRTC had sought Rs 7,776.08 crore for free travel and other concessions, Rs 855.01 crore for debt servicing, Rs 406.27 crore for depots and stations, and Rs 241.37 crore for 666 new buses. Instead, the government appears to have prioritised only the Mahalakshmi outlay.

For long-term investors, the wider lesson is straightforward: social programmes can be politically popular and economically expensive at the same time. If the state does not fully fund them, the burden is shifted to the operator, and eventually to taxpayers, workers or service quality. That can weaken the economics of public transport even as ridership rises.

There is also a governance angle. Telangana’s transport minister has said the government will move toward merging TSRTC into the state government after union recognition elections, a step that could improve labour stability but also deepen the fiscal responsibility sitting on the state’s balance sheet. The question now is whether the government can turn promises into regular cash releases before arrears become a structural drag on the company’s finances.

For investors watching Indian state-backed infrastructure and transport, TSRTC is a useful case study in how welfare spending and balance-sheet health can collide. The scheme may be good politics, but the funding discipline will determine whether it remains sustainable. That makes the reimbursement schedule, not the headline subsidy benefit, the key number to watch.